Skip to content

Studying the Anti-Ageing Benefits of Bhallataka Rasayana: how it affects the Body, Blood, and Genes

Evaluation of an Anti-Ageing effect of Bhallataka Rasayana through Physiological, Biochemical, and Gene Expression Analysis. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085243
Enrollment
30
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Devashish Santosh Dahatre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Volunteer and Devoid of any Co-Morbidities Age- Between 45 to 60 years Gender- Both Male and Female Class- All Socio-Economic Classes

Exclusion criteria

Exclusion criteria: Pitta Prakriti All Systemic Disorders Alcoholic Person Tobacco Consuming Person Lactating Mother, Pregnant Women

Design outcomes

Primary

MeasureTime frame
This outcome aims to scientifically validate the traditional claims of Bhallataka Rasayana as an anti-ageing agent by evaluating its effects through biochemical parameters and gene expression analysis. RNA sequencing of peripheral blood mononuclear cells (PBMCs) will be performed to identify transcriptional changes associated with ageing, cellular stress, and key ageing-related molecular pathwayTimepoint: 90 Days

Secondary

MeasureTime frame
Improvement in Cognitive Function, Skin Radiance and Physical Appearance, Safety and Tolerability Effectiveness of Pathya-Apathya (dietary discipline) in enhancing the outcomes of Bhallataka Rasayana. Timepoint: 90 Days

Countries

India

Contacts

Public ContactDr Rahul Jadhav

Parul Institute of Ayurveda and Research, Parul University, Vadodara, Gujarat

rahul.jadhav21814@paruluniversity.ac.in9960855548

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026